Fig. 1From: Eukaryotic translation initiation factor 5A2 (eIF5A2) regulates chemoresistance in colorectal cancer through epithelial mesenchymal transitionDifferent doxorubicin sensitivity in colon cancer cells. Four human colon cancer cell lines including HCT116, HT29 (a), and LOVO, SW480 (b) were incubated with doxorubicin for 48 h. Cell viability was measured using CCK-8 method. Western blot was performed to determine eIF5A2 expression in HCT116, HT29, LOVO and SW480 cells (c). *P < 0.05, compared with LOVO; #P < 0.05, compared with SW480Back to article page